Related Experiment Videos
Non-Hodgkin's lymphomas in elderly patients
1Department of Medicine, Toronto Hospital, Ontario, Canada.
Leukemia & Lymphoma
|June 1, 1993
Summary
Older adults with non-Hodgkin's lymphoma (NHL) face poorer prognoses due to age-related factors. Research explores novel chemotherapy regimens to improve outcomes while managing toxicity in elderly patients.
Area of Science:
- Hematology
- Oncology
- Geriatrics
Background:
- Non-Hodgkin's lymphoma (NHL) median age of onset is 65 years.
- Increasing age is associated with adverse prognosis in NHL patients.
- Age-related factors like comorbidities and altered pharmacokinetics complicate treatment.
Purpose of the Study:
- To review factors influencing outcomes in elderly NHL patients.
- To discuss novel chemotherapy strategies for older adults.
- To explore customized therapeutic approaches for elderly NHL patients.
Main Methods:
- Review of retrospective studies on age and NHL prognosis.
- Analysis of prospective single-arm and randomized clinical trials.
- Discussion of challenges in chemotherapy administration for the elderly.
Main Results:
- Age-related factors often confound prognosis data.
- Novel regimens show improved remission and survival but increased toxicity.
- Strategies like oral chemotherapy and dose fractionation are being investigated.
Conclusions:
- Optimizing chemotherapy for elderly NHL patients requires balancing efficacy and toxicity.
- Further research into tailored treatment strategies is crucial.
- Developing flexible, customized therapy can improve outcomes for older adults with NHL.